What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Thomas Krausz spends much of his time researching Pathology, Cancer research, Internal medicine, Immunohistochemistry and Lung.
His study ties his expertise on Multiple myeloma together with the subject of Pathology.
The study incorporates disciplines such as Tumor progression, Metastasis, Immunology and Molecular biology in addition to Cancer research.
His Internal medicine research incorporates themes from Endocrinology and Cardiology.
The various areas that Thomas Krausz examines in his Immunohistochemistry study include Neoplasm, Ultrastructure, Anatomy and Undifferentiated carcinoma.
In Lung, he works on issues like Adenocarcinoma, which are connected to Carbohydrate metabolism.
His most cited work include:
- Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease (671 citations)
- C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction (438 citations)
- Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors (390 citations)
What are the main themes of his work throughout his whole career to date?
Thomas Krausz mostly deals with Pathology, Internal medicine, Immunohistochemistry, Cancer research and Endocrinology.
His studies in Pathology integrate themes in fields like Lung and Adenocarcinoma.
His work focuses on many connections between Internal medicine and other disciplines, such as Oncology, that overlap with his field of interest in Pembrolizumab.
His Immunohistochemistry study incorporates themes from Staining and BAP1.
His studies deal with areas such as Cancer, Ovarian cancer and Metastasis as well as Cancer research.
Thomas Krausz frequently studies issues relating to Cell culture and Endocrinology.
He most often published in these fields:
- Pathology (54.84%)
- Internal medicine (17.20%)
- Immunohistochemistry (13.98%)
What were the highlights of his more recent work (between 2011-2021)?
- Pathology (54.84%)
- Immunohistochemistry (13.98%)
- Cancer research (11.47%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pathology, Immunohistochemistry, Cancer research, Mesothelioma and Internal medicine.
His Pathology study frequently involves adjacent topics like Fluorescence in situ hybridization.
Thomas Krausz has researched Immunohistochemistry in several fields, including In situ hybridization and Mitotic index.
His Cancer research research integrates issues from Epithelioid sarcoma, Tumor microenvironment, Cancer, microRNA and Tumor suppressor gene.
The concepts of his Mesothelioma study are interwoven with issues in Malignancy, Polyclonal antibodies, Mesothelium and Monoclonal.
His Internal medicine research is multidisciplinary, incorporating elements of Oncology and Peritoneal mesothelioma.
Between 2011 and 2021, his most popular works were:
- BAP1 and cancer (358 citations)
- Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. (330 citations)
- Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. (275 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His main research concerns Pathology, Mesothelioma, Cancer research, Differential diagnosis and BAP1.
His research brings together the fields of Fluorescence in situ hybridization and Pathology.
His Mesothelioma research includes themes of Malignant transformation, Internal medicine and Oncology.
His Cancer research research includes elements of Epithelioid sarcoma, HMGA2, microRNA, Tumor microenvironment and Chemotaxis.
His work in Differential diagnosis covers topics such as Lung which are related to areas like Adenocarcinoma.
As a part of the same scientific study, Thomas Krausz usually deals with the BAP1, concentrating on Cutaneous melanoma and frequently concerns with Germline.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
